Independent intelligence for the laboratory world

Resonant Adds Clinical-Trial Equipment and Calibration Through Labfish Deal

Resonant Clinical Solutions acquired Labfish, adding European laboratory-equipment rental, calibration and cross-border logistics capabilities.

Press release summary

Resonant Clinical Solutions has acquired Labfish rental solutions GmbH and its U.S. and U.K. affiliates, expanding Resonantโ€™s laboratory-equipment rental, calibration and logistics services for clinical trials. Financial terms were not disclosed.

Hamburg, Germany-based Labfish rents equipment that includes balances, freezers, refrigerators, infusion pumps and monitors. It also provides kitting, ancillary supplies, in-house calibration and importer-of-record and exporter-of-record services. Resonant said Labfish works with partner depots in Argentina, Israel, Turkey and China and supports trial sites in more than 70 countries. Labfish is ISO 9001-certified and operates an in-house calibration facility serving European clinical trials.

Resonant said the acquisition extends its Equipment & Ancillaries business in Europe. The combined company serves pharmaceutical and biotechnology companies, contract research and manufacturing organizations, and diagnostic and reference laboratories.

Why it matters for laboratories

Multicountry trials depend on consistent equipment configuration, calibration records, temperature control and import documentation across sites. A wider rental and service network may simplify deployment and reduce the need for sponsors to manage separate regional vendors. Laboratories and trial teams should still review local accreditation scope, calibration traceability, service response times and equipment-qualification responsibilities; the release does not provide performance metrics for the combined operation.

Original source: Resonant Clinical Solutions release distributed through PR Newswire, Sept. 30, 2026.

Join the Discussion

Share your experience or ask a question about this article. Please keep comments relevant and respectful.

Leave a Reply

Your email address will not be published. Required fields are marked *